These results demonstrated that BCL inhibits cardiac hypertrophy by a SIRT3-dependent mechanism, indicating its potential use in treating cardiac hypertrophy and heart failure (Cai et al., 2023). The gene discussed is SIRT3; the disease is cardiac hypertrophy.